Reconstruction of Tissue-Specific Metabolic Networks Using CORDA
暂无分享,去创建一个
[1] K. Kothapalli,et al. FADS2 Function Loss at the Cancer Hotspot 11q13 Locus Diverts Lipid Signaling Precursor Synthesis to Unusual Eicosanoid Fatty Acids , 2011, PloS one.
[2] Min Kyung Kim,et al. Methods for integration of transcriptomic data in genome-scale metabolic models , 2014, Computational and structural biotechnology journal.
[3] Anastasia K Yocum,et al. The role of sarcosine metabolism in prostate cancer progression. , 2013, Neoplasia.
[4] Jie Zheng,et al. Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review). , 2012, Oncology letters.
[5] S. Prescott,et al. Fatty acid CoA ligase 4 is up-regulated in colon adenocarcinoma. , 2001, Cancer research.
[6] Andrea Viale,et al. Tumors and mitochondrial respiration: a neglected connection. , 2015, Cancer research.
[7] Christian Frezza,et al. Defects in mitochondrial metabolism and cancer , 2014, Cancer & metabolism.
[8] D. Horsfall,et al. Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] Monica L. Mo,et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.
[10] E. Baudin,et al. Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network. , 2014, European journal of endocrinology.
[11] Dragana Nikitovic,et al. Glycosaminoglycans: key players in cancer cell biology and treatment , 2012, The FEBS journal.
[12] B. Palsson,et al. Large-scale in silico modeling of metabolic interactions between cell types in the human brain , 2010, Nature Biotechnology.
[13] Zoran Nikoloski,et al. Generalized framework for context-specific metabolic model extraction methods , 2014, Front. Plant Sci..
[14] Natapol Pornputtapong,et al. Reconstruction of Genome-Scale Active Metabolic Networks for 69 Human Cell Types and 16 Cancer Types Using INIT , 2012, PLoS Comput. Biol..
[15] M Cascante,et al. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. , 2001, European journal of biochemistry.
[16] Chao Sun,et al. Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation , 2014, Cancer Cell International.
[17] E. Lundberg,et al. Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.
[18] Z. Nikoloski,et al. Context-Specific Metabolic Model Extraction Based on Regularized Least Squares Optimization , 2015, PloS one.
[19] C. Gille,et al. HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology , 2010, Molecular systems biology.
[20] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[21] Lan Thi Hoàng Nguyễn,et al. The role of thiamine in cancer: possible genetic and cellular signaling mechanisms. , 2013, Cancer genomics & proteomics.
[22] Amanda E Toland,et al. Salivary gland cancer in BRCA-positive families: a retrospective review. , 2014, JAMA otolaryngology-- head & neck surgery.
[23] F. Claessens,et al. Squalene Synthase, a Determinant of Raft-associated Cholesterol and Modulator of Cancer Cell Proliferation* , 2007, Journal of Biological Chemistry.
[24] E J Thonar,et al. Keratan sulfate levels in sera of patients bearing cartilage tumors , 1987, Cancer.
[25] M. Bartlett,et al. Up-regulation of vitamin B1 homeostasis genes in breast cancer. , 2013, The Journal of nutritional biochemistry.
[26] Bernhard O. Palsson,et al. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1 , 2010, BMC Systems Biology.
[27] Lihong Ye,et al. MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA. , 2014, Biochemical and biophysical research communications.
[28] Robert L. Smith,et al. Direction Choice for Accelerated Convergence in Hit-and-Run Sampling , 1998, Oper. Res..
[29] H. J. Greenberg,et al. Monte Carlo sampling can be used to determine the size and shape of the steady-state flux space. , 2004, Journal of theoretical biology.
[30] R. Moreno-Sánchez,et al. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. , 2010, Molecular aspects of medicine.
[31] Maria Paola Costi,et al. Novel approaches for targeting thymidylate synthase to overcome the resistance and toxicity of anticancer drugs. , 2010, Journal of medicinal chemistry.
[32] Huaqing Zhao,et al. The H+-Linked Monocarboxylate Transporter (MCT1/SLC16A1): A Potential Therapeutic Target for High-Risk Neuroblastoma , 2006, Molecular Pharmacology.
[33] Seongwon Seo,et al. BMC Systems Biology BioMed Central Methodology article , 2009 .
[34] Mathias Uhlen,et al. Identifying anti-growth factors for human cancer cell lines through genome-scale metabolic modeling , 2015, Scientific Reports.
[35] Claude Chelala,et al. Genome-Wide Analysis of Pancreatic Cancer Using Microarray-Based Techniques , 2008, Pancreatology.
[36] P. Bougnoux,et al. n-3 polyunsaturated fatty acids and cancer. , 1999, Current opinion in clinical nutrition and metabolic care.
[37] A. Mittelman,et al. Adenosine deaminase activity in patients with renal adenocarcinoma , 1977, Cancer.
[38] Z N Oltvai,et al. Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells , 2013, Cell Death and Disease.
[39] Sun-Hwa Park,et al. Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells , 2014, BMC Cancer.
[40] E. Ruppin,et al. Predicting metabolic biomarkers of human inborn errors of metabolism , 2009, Molecular systems biology.
[41] I. Nookaew,et al. Integration of clinical data with a genome-scale metabolic model of the human adipocyte , 2013, Molecular systems biology.
[42] Aarash Bordbar,et al. A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology , 2011, BMC Systems Biology.
[43] Emma Saavedra,et al. Energy metabolism in tumor cells , 2007, The FEBS journal.
[44] C. Maranas,et al. Recent advances in the reconstruction of metabolic models and integration of omics data. , 2014, Current opinion in biotechnology.
[45] Jianxin Xie,et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. , 2014, Molecular cell.
[46] Yang Liu,et al. Increased MTHFD2 expression is associated with poor prognosis in breast cancer , 2014, Tumor Biology.
[47] R. Mahadevan,et al. The effects of alternate optimal solutions in constraint-based genome-scale metabolic models. , 2003, Metabolic engineering.
[48] P. Skehan,et al. Membrane-active drugs potentiate the killing of tumor cells by D-glucosamine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[49] Jason A. Papin,et al. Applications of genome-scale metabolic reconstructions , 2009, Molecular systems biology.
[50] B. Jang,et al. D-glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K. , 2007, Biochemical and biophysical research communications.
[51] Intawat Nookaew,et al. Proteome- and transcriptome-driven reconstruction of the human myocyte metabolic network and its use for identification of markers for diabetes. , 2015, Cell reports.
[52] Bernhard O. Palsson,et al. Context-Specific Metabolic Networks Are Consistent with Experiments , 2008, PLoS Comput. Biol..
[53] A. Theocharis,et al. The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. , 2008, In vivo.
[54] Wei Huang,et al. Validation and target gene screening of hsa‐miR‐205 in lung squamous cell carcinoma , 2014, Chinese medical journal.
[55] Jens Nielsen,et al. Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism , 2015, Scientific Reports.
[56] D F Horrobin,et al. Differential killing of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids. , 1986, Journal of the National Cancer Institute.
[57] B. Palsson,et al. Constraining the metabolic genotype–phenotype relationship using a phylogeny of in silico methods , 2012, Nature Reviews Microbiology.
[58] D F Horrobin,et al. Selective killing of human cancer cells by polyunsaturated fatty acids. , 1985, Prostaglandins, leukotrienes, and medicine.
[59] Nathan E. Lewis,et al. The evolution of genome-scale models of cancer metabolism , 2013, Front. Physiol..
[60] Robert V Farese,et al. Cellular fatty acid metabolism and cancer. , 2013, Cell metabolism.
[61] Eero Pukkala,et al. Cancer risk after renal transplantation in the nordic countries, 1964–1986 , 1995, International journal of cancer.
[62] Ines Thiele,et al. Predicting the impact of diet and enzymopathies on human small intestinal epithelial cells , 2013, Human molecular genetics.
[63] Dmitri D. Pervouchine,et al. The human transcriptome across tissues and individuals , 2015, Science.
[64] A Senra Varela,et al. Serum ceruloplasmin as a diagnostic marker of cancer. , 1997, Cancer letters.
[65] S. Lakhani,et al. Salivary gland-like tumours of the breast: surgical and molecular pathology , 2003, Journal of clinical pathology.
[66] Gabriela Kalna,et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase , 2011, Nature.
[67] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[68] I. Amelio,et al. Serine and glycine metabolism in cancer☆ , 2014, Trends in biochemical sciences.
[69] Elina Hyppönen,et al. Vitamin D and adipose tissue—more than storage , 2014, Front. Physiol..
[70] I. Nookaew,et al. Chromosome 3p loss of heterozygosity is associated with a unique metabolic network in clear cell renal carcinoma , 2014, Proceedings of the National Academy of Sciences.
[71] J. Dickerson,et al. The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. , 1976, Oncology.
[72] D. Horsfall,et al. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer. , 1999, Cancer research.
[73] Yoshihiro Fujita,et al. Alteration of adenosine deaminase levels in peripheral blood lymphocytes of patients with gastric cancer , 1985, The Japanese journal of surgery.
[74] M. Guppy,et al. Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.
[75] R. Johnson,et al. Decreased lymphocyte adenosine deaminase activity in tumor patients. , 1976, Cancer research.
[76] Zachary A. King,et al. Constraint-based models predict metabolic and associated cellular functions , 2014, Nature Reviews Genetics.
[77] R. Sutherland,et al. Molecular markers of prostate cancer outcome. , 2005, European journal of cancer.
[78] Nikos Vlassis,et al. Fast Reconstruction of Compact Context-Specific Metabolic Network Models , 2013, PLoS Comput. Biol..
[79] H Matsui,et al. Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer , 2012, Prostate Cancer and Prostatic Diseases.
[80] Philip E. Bourne,et al. Drug Off-Target Effects Predicted Using Structural Analysis in the Context of a Metabolic Network Model , 2010, PLoS Comput. Biol..
[81] Ronan M. T. Fleming,et al. A community-driven global reconstruction of human metabolism , 2013, Nature Biotechnology.
[82] Markus J. Herrgård,et al. Network-based prediction of human tissue-specific metabolism , 2008, Nature Biotechnology.
[83] Jeffrey D Orth,et al. What is flux balance analysis? , 2010, Nature Biotechnology.
[84] Dong Kyung Chang,et al. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation , 2013, BMC Cancer.
[85] B. Palsson,et al. Uniform sampling of steady-state flux spaces: means to design experiments and to interpret enzymopathies. , 2004, Biophysical journal.
[86] E. Ruppin,et al. Computational reconstruction of tissue-specific metabolic models: application to human liver metabolism , 2010, Molecular systems biology.
[87] Bernhard O. Palsson,et al. GIM3E: condition-specific models of cellular metabolism developed from metabolomics and expression data , 2013, Bioinform..
[88] Bernhard O. Palsson,et al. The human metabolic reconstruction Recon 1 directs hypotheses of novel human metabolic functions , 2011, BMC Systems Biology.
[89] E. Gottlieb,et al. Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.
[90] Peng Huang,et al. Superoxide dismutase as a target for the selective killing of cancer cells , 2000, Nature.
[91] T. Tsuruo,et al. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy , 2009, British Journal of Cancer.
[92] George W. Yip,et al. Therapeutic value of glycosaminoglycans in cancer , 2006, Molecular Cancer Therapeutics.
[93] N. Wall,et al. Antimetabolite Treatment for Pancreatic Cancer , 2014, Chemotherapy.
[94] Jason A. Papin,et al. Integration of expression data in genome-scale metabolic network reconstructions , 2012, Front. Physio..
[95] Jung Hun Song,et al. An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases. , 2006, The Journal of clinical endocrinology and metabolism.
[96] K. Hemminki,et al. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? , 2003, European journal of cancer.
[97] D. Horsfall,et al. Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[98] T. Cotter,et al. DUOX enzyme activity promotes AKT signalling in prostate cancer cells. , 2012, Anticancer research.
[99] J. Nielsen,et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome‐scale metabolic modeling , 2014, Molecular systems biology.
[100] V. Mootha,et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer , 2014, Nature Communications.
[101] M. Uhlén,et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.
[102] Jae Yong Ryu,et al. Reconstruction of genome-scale human metabolic models using omics data. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[103] Ronan M. T. Fleming,et al. Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 , 2007, Nature Protocols.
[104] Nathan E Lewis,et al. Analysis of omics data with genome-scale models of metabolism. , 2013, Molecular bioSystems.
[105] J. H. Quastel,et al. Inhibition of Tumour Growth by D-Glucosamine , 1953, Nature.
[106] A. Bordbar,et al. Using the reconstructed genome‐scale human metabolic network to study physiology and pathology , 2012, Journal of internal medicine.
[107] Natapol Pornputtapong,et al. Human metabolic atlas: an online resource for human metabolism , 2015, Database J. Biol. Databases Curation.
[108] Nathan D. Price,et al. Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE , 2012, BMC Systems Biology.
[109] Judy Yan,et al. PKM2 contributes to cancer metabolism. , 2015, Cancer letters.
[110] Dan Gao,et al. Vitamin D signalling in adipose tissue , 2012, British Journal of Nutrition.
[111] Charles DeLisi,et al. Pathway-based classification of cancer subtypes , 2012, Biology Direct.
[112] J. Bertino,et al. Cancer research: from folate antagonism to molecular targets. , 2009, Best practice & research. Clinical haematology.
[113] Xianglin Shi,et al. Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. , 2009, Journal of hepatology.
[114] Nathan E. Lewis,et al. Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice , 2014, PloS one.
[115] G. Kloss,et al. Accumulation of radioiodinated tyrosine derivatives in the adrenal medulla and in melanomas , 1979, European Journal of Nuclear Medicine.
[116] John T. Wei,et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.
[117] Kristiina Iljin,et al. High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion , 2012, Oncotarget.
[118] M. Mańczak,et al. Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. , 2001, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[119] B. Palsson,et al. Candidate Metabolic Network States in Human Mitochondria , 2005, Journal of Biological Chemistry.
[120] Debashis Ghosh,et al. Erratum: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression (Nature (2009) 457 (910-914) DOI: 10.1038/nature07762) , 2013 .
[121] S. Kaye,et al. New antimetabolites in cancer chemotherapy and their clinical impact. , 1998, British Journal of Cancer.
[122] B. Palsson,et al. Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions , 2010, Molecular systems biology.
[123] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[124] Salvatore Piscuoglio,et al. Are acinic cell carcinomas of the breast and salivary glands distinct diseases? , 2015, Histopathology.
[125] Brooke L. Fridley,et al. Gene set analysis of purine and pyrimidine antimetabolites cancer therapies , 2011, Pharmacogenetics and genomics.
[126] M. Krajinovic,et al. Dihydrofolate Reductase Gene Variations in Susceptibility to Disease and Treatment Outcomes , 2010, Current genomics.
[127] S. Morris. Regulation of enzymes of the urea cycle and arginine metabolism. , 2002, Annual review of nutrition.
[128] S. Lee,et al. Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery , 2011, Molecular systems biology.